Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease

被引：10
|
作者：
Ebata, S. [1 ]
Yoshizaki, A. [1 ]
Fukasawa, T. [1 ]
Nakamura, K. [1 ]
Yamashita, T. [1 ]
Miura, S. [1 ]
Saigusa, R. [1 ]
Ichimura, Y. [1 ]
Takahashi, T. [1 ]
Hirabayashi, M. [1 ]
Taniguchi, T. [1 ]
Akamata, K. [1 ]
Asano, Y. [1 ]
Sato, S. [1 ]
机构：
[1] Univ Tokyo, Dept Dermatol, Fac Med, Tokyo, Japan
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2017年 / 46卷 / 03期
关键词：
D O I：
10.1080/03009742.2016.1231341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：247 / 249
页数：3
相关论文
共 50 条
  • [1] FREQUENCY OF INFECTIONS AND DECREASE OF IGG IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS ON RITUXIMAB AND IMMUNOSUPPRESSANT THERAPY
    Garzanova, Liudmila
    Ananatva, Lidia
    Koneva, Olga
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    CHEST, 2022, 162 (04) : 1259A - 1259A
  • [2] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [3] Systemic sclerosis-associated interstitial lung disease
    Perelas, Apostolos
    Silver, Richard M.
    Arrossi, Andrea, V
    Highland, Kristin B.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (03): : 304 - 320
  • [4] Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus
    Sumida, Hayakazu
    Asano, Yoshihide
    Tamaki, Zenshiro
    Aozasa, Naohiko
    Taniguchi, Takashi
    Takahashi, Takehiro
    Toyama, Tetsuo
    Ichimura, Yohei
    Noda, Shinji
    Akamata, Kaname
    Miyazaki, Miki
    Kuwano, Yoshihiro
    Yanaba, Koichi
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2014, 41 (05): : 418 - 420
  • [5] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Daoussis, Dimitrios
    Andonopoulos, Andrew P.
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) : 841 - 842
  • [6] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [7] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Andrew P. Andonopoulos
    Rheumatology International, 2011, 31 : 841 - 842
  • [8] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [9] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Andreasson, Kristofer
    Wuttge, Dirk M.
    Wollheim, Frank A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1595 - 1596
  • [10] Management of systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Jaafar, Sara
    Vummidi, Dharshan
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 241 - 249
12345